Results 131 to 140 of about 16,306 (216)

7-Substituted 2-Nitro-5,6-dihydroimidazo[2,1-b][1,3]oxazines: Novel Antitubercular Agents Lead to a New Preclinical Candidate for Visceral Leishmaniasis

, 2017
Andrew M. Thompson, P. D. T. O’Connor, Andrew J. Marshall, Vanessa Yardley, Louis Maes, Suman Gupta, Delphine Launay, Stéphanie Braillard, Eric Chatelain, Scott G. Franzblau, Baojie Wan, Yuehong Wang, Zhenkun Ma, Christopher B. Cooper, William A. Denny   +14 more
openalex   +1 more source

Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents. [PDF]

Bioorg Med Chem Lett
Yang B, Sukheja P, Qin B, Li G, Bare GAL, Cascioferro A, Love MS, Petrassi HM, Sharpless KB, McNamara CW, Chatterjee AK.   +10 more
europepmc   +1 more source

Synthesis of fluoro-rich pyrimidine-5-carbonitriles as antitubercular agents against H37Rv receptor

Heterocyclic Communications, 2022
Kapadiya Khushal M., Kavadia Kishor M., Khedkar Vijay M., Dholaria Piyush V., Jivani Amita J., Khunt Ranjan C.   +5 more
doaj   +1 more source

Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting Mtb-FtsZ as antitubercular agents. [PDF]

RSC Med Chem, 2021
Haranahalli K, Tong S, Kim S, Awwa M, Chen L, Knudson SE, Slayden RA, Singleton E, Russo R, Connell N, Ojima I.   +10 more
europepmc   +1 more source

Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase. [PDF]

PLoS One
Mahnashi MH, Avunoori S, Gopi S, Shaikh IA, Saif A, Bantun F, Faidah HS, Alhadi AA, Alshehri JH, Alharbi AA, S R PK, Joshi SD.   +11 more
europepmc   +1 more source

Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide derivatives as potential antitubercular agents. [PDF]

RSC Med Chem
González-González A, Sánchez-Sánchez O, Wan B, Franzblau S, Palos I, Espinoza-Hicks JC, Moreno-Rodríguez A, Martínez-Vázquez AV, Lara-Ramírez EE, Ortiz-Pérez E, Paz-González AD, Rivera G.   +11 more
europepmc   +1 more source

Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy]benzyl)arylamine derivatives as potential antitubercular agents. [PDF]

Drug Dev Res, 2020
Verma R, Boshoff HIM, Arora K, Bairy I, Tiwari M, Varadaraj BG, Shenoy GG.   +6 more
europepmc   +1 more source

Acyloxybenzyl and Alkoxyalkyl Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents. [PDF]

ACS Med Chem Lett, 2018
Courtens C, Risseeuw M, Caljon G, Cos P, Van Calenbergh S.   +4 more
europepmc   +1 more source

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. [PDF]

J Enzyme Inhib Med Chem, 2019
Chiarelli LR, Mori M, Beretta G, Gelain A, Pini E, Sammartino JC, Stelitano G, Barlocco D, Costantino L, Lapillo M, Poli G, Caligiuri I, Rizzolio F, Bellinzoni M, Tuccinardi T, Villa S, Villa S, Meneghetti F.   +17 more
europepmc   +1 more source

Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents. [PDF]

ACS Med Chem Lett, 2018
Li L, Lv K, Yang Y, Sun J, Tao Z, Wang A, Wang B, Wang H, Geng Y, Liu M, Guo H, Lu Y.   +11 more
europepmc   +1 more source